UBS has revised its price target for Aixtron, lowering it from €20.90 to €14.90 after the company's recent quarterly results.
The Swiss bank has maintained a "Neutral" rating on Aixtron's stock. Analyst Madeleine Jenkins stated that the adjustment reflects expectations of a delayed market recovery, now predicted to occur in 2025. This has led to significant reductions in earnings forecasts for both 2025 and 2026.
The report highlights a lack of positive price drivers for Aixtron's shares, indicating challenges for the company in the current market environment.